Skip to main content
Bulletin of the World Health Organization logoLink to Bulletin of the World Health Organization
. 1982;60(5):643–660.

Hereditary anaemias: genetic basis, clinical features, diagnosis, and treatment*

WHO Working Group
PMCID: PMC2536044  PMID: 6983923

Abstract

The hereditary anaemias present a major genetic health problem that contributes considerably to childhood mortality and morbidity in many developing countries. This article summarizes recent scientific and technical advances in knowledge concerning the genes involved and their interaction to produce major haemoglobinopathies, the clinical pictures of these conditions, and their diagnostic criteria. Though there is no definitive cure, supportive treatment for the haemoglobinopathies has improved significantly, offering better quality of life and improved survival, and should be attempted for all such patients. For sickle cell disease, this comprises a simple set of rules that should be incorporated into existing medical care, whereas for thalassaemia, a regimen of intensive blood transfusion and regular subcutaneous infusion of deferoxamine is recommended. This treatment is stressful and probably too expensive to be applied in many developing countries until the birth rate of patients needing it can be sufficiently reduced by community control programmes.

Full text

PDF
643

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Busslinger M., Moschonas N., Flavell R. A. Beta + thalassemia: aberrant splicing results from a single point mutation in an intron. Cell. 1981 Dec;27(2 Pt 1):289–298. doi: 10.1016/0092-8674(81)90412-8. [DOI] [PubMed] [Google Scholar]
  2. Jones R. W., Old J. M., Trent R. J., Clegg J. B., Weatherall D. J. Major rearrangement in the human beta-globin gene cluster. Nature. 1981 May 7;291(5810):39–44. doi: 10.1038/291039a0. [DOI] [PubMed] [Google Scholar]
  3. Kan Y. W., Dozy A. M. Antenatal diagnosis of sickle-cell anaemia by D.N.A. analysis of amniotic-fluid cells. Lancet. 1978 Oct 28;2(8096):910–912. doi: 10.1016/s0140-6736(78)91629-x. [DOI] [PubMed] [Google Scholar]
  4. Modell B. Total management of thalassaemia major. Arch Dis Child. 1977 Jun;52(6):489–500. doi: 10.1136/adc.52.6.489. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Moschonas N., de Boer E., Grosveld F. G., Dahl H. H., Wright S., Shewmaker C. K., Flavell R. A. Structure and expression of a cloned beta o thalassaemic globin gene. Nucleic Acids Res. 1981 Sep 11;9(17):4391–4401. doi: 10.1093/nar/9.17.4391. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Traeger J., Wood W. G., Clegg J. B., Weatherall D. J. Defective synthesis of HbE is due to reduced levels of beta E mRNA. Nature. 1980 Dec 4;288(5790):497–499. doi: 10.1038/288497a0. [DOI] [PubMed] [Google Scholar]
  7. Tuan D., Murnane M. J., deRiel J. L., Forget B. G. Heterogeneity in the molecular basis of hereditary persistence of fetal haemoglobin. Nature. 1980 May 29;285(5763):335–337. doi: 10.1038/285335a0. [DOI] [PubMed] [Google Scholar]
  8. Westaway D., Williamson R. An intron nucleotide sequence variant in a cloned beta +-thalassaemia globin gene. Nucleic Acids Res. 1981 Apr 24;9(8):1777–1788. doi: 10.1093/nar/9.8.1777. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Bulletin of the World Health Organization are provided here courtesy of World Health Organization

RESOURCES